Cannovum Iberia LDA is the Portuguese subsidiary of the German pharmaceutical cannabis company Cannovum AG. Cannovum joins forces with Portuguese entrepreneurs who are very experienced in cultivating high quality medical cannabis with a sustainable approach. This approach leads to medical cannabis that is sunlight-grown and free of chemical pesticides. The joint venture allows Cannovum to provide Portuguese patients with cannabis-based medicines, because every patient deserves the best therapy.
The company Cannovum AG is the first German pharmaceutical cannabis company that got listed on the stock exchange in Germany. Although Germany was the starting point, we are a European company and founding the Portuguese brand was the first step to provide patients all throughout Europe with medical cannabis.
Our Medical Advisory Board consists of experts and pioneers in cannabis therapy. The members of our board advise us with their scientific expertise and longterm practical experience. Head of the Medical Advisory Board is Dr. med. Dipl.-Chem. Konrad F. Cimander.
CEO & Co-Founder
Pia is the Chief Executive Officer of Cannovum AG. Prior to founding Cannovum, she led the company management in the renewable energy sector. This gave her not only the opportunity to strengthen her expertise on how to run operational businesses, but also to develop the implementation of resource-saving approaches. Pia’s aim is to fully harness the potential of the cannabis plant and provide patients in Germany and Europe with medical cannabis that is sunlight ripened, free of chemical pesticides and sustainably grown.
Co-Founder
Marius is Co-Founder of Cannovum AG and has years of pharmaceutical experience. He worked for 13 years in various roles in the pharmaceutical industry, mostly with an international focus. Most recently, he developed new processes and systems in California and Germany as a project manager for the pharmaceutical company Bayer in the field of biological development. Marius incorporates his expertise in pharmaceutical market advancement into developing Cannovum’s cannabis-based medicines to provide the best therapy for each patient.
Head of Marketing & Medical Affairs
Sandra has 15 years of experience in the healthcare industry and expertise in marketing. After completing her PhD at the Charité in Berlin, she advised biotech and pharma companies with market entry in Germany. Most recently, she led the medical affairs department and built an educational platform for a Canadian cannabis manufacturer.Since cannabis as medicine is rarely part of pharmaceutical and medical education, she is particularly passionate about spreading more knowledge about the medical-therapeutic use of cannabis. At Cannovum, she takes care of marketing and medical education, and gives customized, free workshops to healthcare professionals.
© 2022 Cannovum Iberia. All rights reserved.
